Digoxin vs Nivolumab

## Digoxin vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Digoxin** and **Nivolumab**.

## Mechanism of Action

**Digoxin**: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Digoxin — 36-48 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Digoxin — C41H64O14; Nivolumab — N/A.

**Molecular Weight**: Digoxin — 780.9430 g/mol; Nivolumab — N/A.

**Type**: Digoxin — Small molecule; Nivolumab — Antibody.